Abstract
Prion diseases, or transmissible spongiform encephalopathies (TSEs), are fatal neurodegenerative disorders of humans and animals caused by conformational conversion of a normal host glycoprotein (PrPC) into an infectious isoform (PrPSc). Whereas the mechanism of PrPSc formation and its infectivity are the subject of intensive research, the exact physiological function of PrPC and the mechanism of neurotoxicity are still unknown. Since prion infections are not limited to a monofunctional event, the PrPC/PrPSc conversion, this review will focus on recent insights into the biology of the prion protein uncovered by proteomic approaches. Recent neuroproteomic studies on the protein profile modifications associated with chronic prion infection in cell systems depicted the co-occurring biochemical abnormalities which are the basis of the prion-induced neuronal death and comprise targets for curative drugs. The involvement of other pathways in prion infectivity opens new insights into understanding of the mechanism of cellular toxicity at the molecular level. This can provide further perspectives for identification of novel therapeutic targets and also allows an integrated paradigm in the prion conversion/toxicity biology.
Keywords: Prion, neurodegeneration, transmissible spongiform encephalopathies, proteomics, mass spectrometry
Current Proteomics
Title: An Update on Prion Biology and Proteomics
Volume: 7 Issue: 1
Author(s): A. R. Roostaee, M. H. Roostaee and X. Roucou
Affiliation:
Keywords: Prion, neurodegeneration, transmissible spongiform encephalopathies, proteomics, mass spectrometry
Abstract: Prion diseases, or transmissible spongiform encephalopathies (TSEs), are fatal neurodegenerative disorders of humans and animals caused by conformational conversion of a normal host glycoprotein (PrPC) into an infectious isoform (PrPSc). Whereas the mechanism of PrPSc formation and its infectivity are the subject of intensive research, the exact physiological function of PrPC and the mechanism of neurotoxicity are still unknown. Since prion infections are not limited to a monofunctional event, the PrPC/PrPSc conversion, this review will focus on recent insights into the biology of the prion protein uncovered by proteomic approaches. Recent neuroproteomic studies on the protein profile modifications associated with chronic prion infection in cell systems depicted the co-occurring biochemical abnormalities which are the basis of the prion-induced neuronal death and comprise targets for curative drugs. The involvement of other pathways in prion infectivity opens new insights into understanding of the mechanism of cellular toxicity at the molecular level. This can provide further perspectives for identification of novel therapeutic targets and also allows an integrated paradigm in the prion conversion/toxicity biology.
Export Options
About this article
Cite this article as:
Roostaee R. A., Roostaee H. M. and Roucou X., An Update on Prion Biology and Proteomics, Current Proteomics 2010; 7 (1) . https://dx.doi.org/10.2174/157016410790979644
DOI https://dx.doi.org/10.2174/157016410790979644 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease
Current Alzheimer Research Anti-Copper Therapies in Alzheimers Disease: New Concepts
Recent Patents on CNS Drug Discovery (Discontinued) A Study on Identification of Nutraceutical Value of New Imidazolone Schiff Base Analogues
Letters in Drug Design & Discovery Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders
Current Medicinal Chemistry Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Translational Imaging of Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Utilisations of Vasopressin and Oxytocin in Mood Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury
Current Medicinal Chemistry Transthyretin Decrease in Plasma of MCI and AD Patients: Investigation of Mechanisms for Disease Modulation
Current Alzheimer Research The Role of Aβ Peptides in Alzheimers Disease
Protein & Peptide Letters Curcumin Exposure Modulates Multiple Pro-Apoptotic and Anti-Apoptotic Signaling Pathways to Antagonize Acetaminophen-Induced Toxicity
Current Neurovascular Research Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Current Signal Transduction Therapy A New Hypothesis of Pathogenesis Based on the Divorce between Mitochondria and their Host Cells: Possible Relevance for Alzheimers Disease
Current Alzheimer Research Localisation of Endothelin-1 and its Receptors in Vascular Tissue as Seen at the Electron Microscopic Level
Current Vascular Pharmacology Is Human Immunodeficiency Virus-Mediated Dementia an Autophagic Defect that Leads to Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Oxidative/Nitrosative Brain Damage in Stress: Possible Target for Neuropsychopharmacological Drugs
Current Medicinal Chemistry - Central Nervous System Agents Stimuli-Responsive Nanoparticles for siRNA Delivery
Current Pharmaceutical Design HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS
Current HIV Research Deep Eutectic Solvents: An Alternative Medium for the Preparation of Organosulfur Compounds
Current Green Chemistry